Authors

1 Department of Clinical Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

2 Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran

3 Department of Pharmacology and Toxicology, Zabol University of Medical Sciences, Zabol, Iran

Abstract

Objective: This study aim to evaluate and compare type and prevalence of drug‑drug 
interactions (DDIs) in prescriptions dispensed in both community and hospital setting in 
Zabol, Iran.
Methods: A total of 2796 prescriptions were collected from community and inpatient and 
outpatient pharmacy of Amir‑al‑momenin only current acting hospital in Zabol, Iran. The 
prescriptions were processed using Lexi‑Comp drug interaction software. The identified 
DDIs were categorized into five classes (A, B, C, D, X).
Findings: Overall 41.6% of prescriptions had at last one potential DDI. The most common 
type of interactions was type C (66%). The percentage of drug interactions in community 
pharmacies were significantly lower than hospital pharmacies (P < 0.0001).
Conclusion: Our results indicate that patients in Zabol are at high risk of adverse drug 
reactions caused by medications due to potential DDIs. Appropriate education for physicians 
about potentially harmful DDIs, as well as active participation of pharmacists in detection 
and prevention of drug‑related injuries, could considerably prevent the consequence of 
DDIs among patients.

Keywords

1. Edwards IR, Aronson JK. Adverse drug reactions: Definitions, 
diagnosis, and management. Lancet 2000;356:1255‑9.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse 
drug reactions in hospitalized patients: A meta‑analysis of 
prospective studies. JAMA 1998;279:1200‑5.
3. Chyka PA. How many deaths occur annually from 
adverse drug reactions in the United States? Am J Med 
2000;109:122‑30.
4. Jankel CA, Fitterman LK. Epidemiology of drug‑drug 
interactions as a cause of hospital admissions. Drug Saf 
1993;9:51‑9.
5. QianY, YeX, DuW, Ren J, SunY, Wang H, et al. Acomputerized 
system for detecting signals due to drug‑drug interactions 
in spontaneous reporting systems. Br J Clin Pharmacol 
2010;69:67‑73.
6. JuurlinkDN, MamdaniM, KoppA, LaupacisA, RedelmeierDA. 
Drug‑drug interactions among elderly patients hospitalized 
for drug toxicity. JAMA 2003;289:1652‑8.
7. Rashidi K, Senobar, Tahaee S. Assessment of drug interactions 
in medical insurance prescriptions in Kurdistan province in 
2000. Sci J Kurdestan Univ 2005;10:78‑84.
8. Nabavizadeh SH, Khoshnevisan F. Drug interactions in 
prescriptions of general practitioners in yasuj city. Armaghan 
Danesh 2003;7:53‑9.
9. Ramezani J. The rate of drug interactions in prescriptions of 
baft general practitioners from March 2010 to August 2010. 
Master Thesis. Kerman University of Medical Sciences; 2010.
10. Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, 
Motola D, et al. Identifying adverse drug reactions associated 
with drug‑drug interactions: Data mining of a spontaneous 
reporting database in Italy. Drug Saf 2010;33:667‑75.
11. Ahmadizar F, Soleymani F, Abdollahi M. Study of drug‑drug 
interactions in prescriptions of general practitioners 
and specialists in iran 2007‑2009. Iran J Pharm Res 2011;
10:921‑31.
12. Soleymani F, Valadkhani M, Dinarvand R. Challenges and 
achievements of promoting rational use of drugs in Iran. Iran 
J Public Health 2009;38 Suppl 1:166‑8.
13. Dambro MR, Kallgren MA. Drug interactions in a clinic using 
COSTAR. Comput Biol Med 1988;18:31‑8.
14. Morteza‑Semnani K, Saeedi M, Qari Pour U. Evaluation 
of drug interactions of Cardiovascular drugs in insurance 
prescriptions of Sari city – 1998‑99. Mazandaran Univ Med 
Sci J 2000;11:93‑87.